project id: TCGA-BLCA; case submitter id: TCGA-C4-A0F6; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 7.8; spectrophotometer method: UV Spec; age at index: 82; days to birth: -29951; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; year of birth: 1926; age at diagnosis: 29951; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 700.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: not reported; alcohol history: Not Reported; cigarettes per day: 1.917808219178082; pack years smoked: 35.0; is ffpe: false; composition: Not Reported; days to collection: 568; days to sample procurement: 0; initial weight: 140.0; portion submitter id: TCGA-C4-A0F6-01A-11; percent monocyte infiltration: 0.0;